The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksASH.L Regulatory News (ASH)

  • There is currently no data for ASH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

23 Nov 2009 17:06

RNS Number : 9522C
Ashley House PLC
23 November 2009
 



Ashley House plc (or "the Company")

Director Change

Ashley House plc the Primary Care Infrastructure specialist, announces today that following the recent acquisition of Sapphire Primary Care Developments ("SPCD") and Lloydspharmacy's resulting 10% shareholding in the Company, Andrew Willetts (46), Finance Director of Lloydspharmacy will join the Board of Ashley House plc as a non-executive director effective immediately 

Andrew Willetts graduated from Keble CollegeOxford in 1985 with a degree in Modern History before going on to qualify as a chartered accountant with what is now PricewaterhouseCoopers in 1991. Since then he has held senior financial roles in a number of companies in the retail and wholesale sectors, including Waterstones Booksellers, and most recently as Director of Shared Services at Hagemeyer (now Rexel SA), prior to joining Lloydspharmacy in July 2003 as Head of Management Reporting.

Andrew was appointed to the position of Director of Financial Operations for Lloydsparmacy, effective 1st January 2005 before being appointed Finance Director Designate on 1st December 2006. Following a three month secondment to Celesio in Stuttgart he became Finance Director of Lloydspharmacy on 1st April 2007. He is also a trustee of the Group pension fund and had main board responsibility for Sapphire Primary Care Developments. 

Andrew's current directorships include the following trading companies

AAH LIMITED

AAH Lloyds Insurance (IoM) Limited

ADMENTA HOLDINGS LIMITED

ADMENTA UK PLC

JOHN BELL & CROYDEN LIMITED

LLOYDS CHEMISTS LIMITED

LLOYDS GROUP PROPERTIES LIMITED

LLOYDS PHARMACY LIMITED

LLOYDS PROPERTIES LIMITED

LLOYDS RETAIL CHEMISTS LIMITED

MPWB (ROMFORD) LIMITED

PHARMAGEN LIMITED

SAVORY & MOORE LIMITED

STEPHEN SMITH LIMITED

Including the companies set out above, Andrew is a director of 387 subsidiary companies of Admenta UK plc, the holding company of Lloydspharmacy. The majority of these companies are dormant. However, a full list of the companies of which Andrew is a director is available from Ashley House on request.

Tony Walters formerly Managing Director of SPCD will be an alternate director to Andrew Willetts. 

Tony (42) graduated with a BA (Hons) Degree in Accounting from Portsmouth Polytechnic (University of Portsmouth) in 1989 before qualifying as a Chartered Accountant in 1992 with Burnett Swayne, Tony has an Executive MBA from Warwick University which he completed in 2003.

Tony joined the Celesio Group in 1996 as Acquisitions Controller for Hills Pharmacy and was involved in the Due Diligence and integration of Lloyds Chemist Plc in 1997 before becoming Director of Acquisitions & Development for Lloydspharmacy in 1999. In 2000 Tony was part of the leadership team that set up what was to become Sapphire Primary Care Developments joining the board of SPCwhen it became a separate company. In 2004 Tony merged Lloydspharmacy's Acquisitions & Development, Property, Shopfitting and Store planning Departments into one new Property & Development department with over 70 personnel, becoming Director of Property & Development before joining Celesio AG in 2005 based in Stuttgart as Director of European Pharmacy Expansion, with the responsibility of looking at market entry into 10 potential new European Countries. In 2006 Tony returned to the UK to become Managing Director of Sapphire Primary Care Developments Limited.

Tony has represented Sapphire as a Director on two Infracare and 2 GB Consortium Companies and currently has responsibility for Lloydspharmacy Acquisitions and Strategy.

The names of all companies and partnerships of which Tony has been a director or partner at any time in the previous five years are set out below:

Sapphire Primary Care Developments Ltd

SPCD (Balsall Common) Ltd

SPCD (Crawcrook) Ltd

SPCD (Silsden) Ltd

SPCD (Didcot) Ltd

SPCD (Davyhulme) Ltd

SPCD (Kincaidston) Ltd

SPCD (Midsomer Norton) Ltd

SPCD (Paisley) Ltd

SPCD (Rugeley) Ltd

SPCD (Sutton in Ashfield) Ltd

SPCD (Northwich) Ltd

SPCD (Shavington) Ltd

Infracare (Midlands) Ltd

Infracare (South West) Ltd

Infracare Dudley Ltd

Infracare Oxford Ltd

Infracare Bristol Ltd

Infracare (South) Ltd

GB Consortium 1 Ltd

GB Consortium 2 Ltd

CCP Fundco 1 Ltd

Coventry Care Partnership Ltd

Jonathan Holmes, Chief Executive of Ashley House plc, said:

 "We are delighted to welcome Andrew to our Board as we look to strengthen our team and develop a close working relationship with our new joint venture partnersAndrew and Tony both bring a wealth of experience particularly in the pharmacy area and we look forward to the future successes of both Ashley House and Lloydspharmacy"

There are no other matters which are required to be announced pursuant to paragraph (g) of Schedule 2 to the AIM Rules.

Enquiries

Ashley House plc 

Jonathan Holmes, Chief Executive

Bruce Walker, Finance Director

Tel: 01628 600340

Citigate Dewe Rogerson 

Sarah Gestetner / Ged Brumby

Tel: 020 7638 9571

Numis Securities Limited 

Nominated Adviser: Oliver Cardigan / Simon Blank

Corporate Broker: David Poutney

Tel: 020 7260 1000

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAILFIDLFLVFIA
Date   Source Headline
11th Dec 20205:30 pmRNSAshley House
11th Dec 20207:00 amRNSReverse Takeover Update and Administration
26th Aug 20201:27 pmRNSProposed Company Voluntary Arrangement
24th Aug 20207:00 amRNSProposed CVA – second adjournment of meeting
18th Aug 20201:05 pmRNSProposed CVA – adjournment of meeting
30th Jul 202012:25 pmRNSProposed CVA and potential Reverse Takeover
7th May 20205:25 pmRNSSale of Interests in PHL and LIFT
30th Mar 20201:59 pmRNSAdministration of F1 Modular and General Update
6th Mar 20207:30 amRNSSuspension - Ashley House Plc
6th Mar 20207:00 amRNSFinancial Update & Suspension of Trading
2nd Mar 202011:53 amRNSHolding(s) in Company
27th Feb 20207:00 amRNSTrading update & Withdrawal from NEX
31st Jan 20207:00 amRNSTrading Update
30th Jan 20201:45 pmRNSHolding(s) in Company
11th Dec 201911:01 amRNSAppointment of Non-executive director
10th Dec 201911:29 amRNSResult of Annual General Meeting
10th Dec 20197:00 amRNSAnnual General Meeting and Trading update
14th Nov 20197:00 amRNSYear End Change, Trading Update and Interim Report
7th Nov 20195:04 pmRNSDirectors' & PDMRs' Dealings
1st Nov 201910:10 amRNSHolding(s) in Company
30th Oct 20197:00 amRNSHolding(s) in Company
24th Oct 20192:23 pmRNSHolding(s) in Company
23rd Oct 20194:29 pmRNSHolding(s) in Company
21st Oct 20197:00 amRNSSale of Interest in Morgan Ashley
2nd Sep 20197:00 amRNSTrading Update
6th Aug 20197:00 amRNSDirectorate Change
5th Aug 20197:00 amRNSDirector/PDMR Shareholding
1st Aug 20192:05 pmRNSSecond Price Monitoring Extn
1st Aug 20192:00 pmRNSPrice Monitoring Extension
1st Aug 20197:00 amRNSTrading Update
5th Jul 20197:00 amRNSTrading Update
28th Jun 201911:51 amRNSHolding(s) in Company
25th Jun 20197:00 amRNSTrading Update
9th May 201910:19 amRNSDirector/PDMR Shareholding
9th May 20197:00 amRNSSchemes Update
3rd May 20191:21 pmRNSDirector/PDMR Shareholding
18th Feb 201912:56 pmRNSHolding(s) in Company
15th Feb 20192:53 pmRNSHolding(s) in Company
15th Feb 20192:50 pmRNSHolding(s) in Company
14th Feb 20194:41 pmRNSSecond Price Monitoring Extn
14th Feb 20194:35 pmRNSPrice Monitoring Extension
1st Feb 20191:38 pmRNSDirectors' & PDMRs' Dealings
31st Jan 20197:00 amRNSInterim Report
28th Jan 20199:40 amRNSAdditional Directorships - Andrew Willetts
16th Jan 201912:50 pmRNSChange of Accounting Year End
1st Nov 20187:00 amRNSDirectors' & PDMRs' Dealings
12th Sep 20181:08 pmRNSResult of AGM
16th Aug 20187:00 amRNSPreliminary Results
9th Aug 20187:00 amRNSJohn Moy
1st Aug 201811:34 amRNSDirectors' & PDMRs' Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.